Management paradigm of central nervous system metastases in NSCLC: an Australian perspective
Date
2023
Authors
Lee, C.K.
Soon, Y.Y.
Jeffree, R.L.
Joshi, R.
Koh, E.S.
Lam, W.S.
Le, H.
Lwin, Z.
Pinkham, M.B.
Siva, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
JTO Clinical and Research Reports, 2023; 4(9):1-10
Statement of Responsibility
Conference Name
Abstract
Life-prolonging central nervous system active systemic therapies for metastatic NSCLC have increased the complexity of managing brain metastases (BMs). Australian medical oncologists, radiation oncologists, and neurosurgeons discussed the evidence guiding the diverse clinical approaches to the management of BM in NSCLC. The Australian context is broadly applicable to other jurisdictions; therefore, we have documented these discussions as principles with broader applications. Patient management was stratified according to clinical and radiologic factors under two broad classifications of newly diagnosed BMs: symptomatic and asymptomatic. Other important considerations include the number and location of metastases, tumor histotypes, molecular subtype, and treatment purpose. Careful consideration of the pace and burden of symptoms, risk of worsening neurologic function at a short interval, and extracranial disease burden should determine whether central nervous system active systemic therapies are used alone or in combination with local therapies (surgery with or without radiation therapy). Most clinical trial evidence currently focuses on historical treatment options or a single treatment modality rather than the optimal sequencing of multiple modern therapies; therefore, an individualized approach is key in a rapidly changing therapeutic landscape.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2023 Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer. This is an open access article under the CCBY-NC-ND license. (http://creativeco mmons.org/licenses/by-nc-nd/4.0/)